Stay updated on Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page's revision/version label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page version.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s footer now shows a newer site “Revision” version (v3.5.3 instead of v3.5.2), indicating a ClinicalTrials.gov site software update.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision: v3.5.2 was added and v3.5.0 was removed.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a site maintenance/version update with no visible changes to the study details.SummaryDifference0.0%

- Check75 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check96 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a backend/UI version bump that does not modify the study content or how users interact with the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.